
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 4 335-339, Copyright © 1993 by American Association for Cancer Research
ARTICLES |
AM Batieha, HK Armenian, EP Norkus, JS Morris, VE Spate and GW Comstock
Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205.
A nested case-control study was conducted in Washington County, MD, to determine whether low serum micronutrients are related to the subsequent risk of cervical cancer. Among the 15,161 women who donated blood for future cancer research during a serum collection campaign in 1974, 18 developed invasive cervical cancer and 32 developed carcinoma in situ during the period January 1975 through May 1990. For each of these 50 cases, two matched controls were selected from the same cohort. The frozen sera of the cases and their matched controls were analyzed for a number of nutrients. The mean serum levels of total carotenoids, alpha-carotene, beta-carotene, cryptoxanthin, and lycopene were lower among cases than they were among controls. When examined by tertiles, the risk of cervical cancer was significantly higher among women in the lower tertiles of total carotenoids (odds ratio 2.7; 95% confidence limit, 1.1-6.4), alpha-carotene (odds ratio, 3.1; 95% confidence limit, 1.3-7.6), and beta-carotene (odds ratio, 3.1; 95% confidence limit, 1.2-8.1) as compared to women in the upper tertiles and the trends were statistically significant. Cryptoxanthin was significantly associated with a lower risk of cervical cancer when examined as a continuous variable. Retinol, lutein, alpha- and gamma-tocopherol, and selenium were not related to cervical cancer risk. Smoking was also strongly associated with cervical cancer. These findings are suggestive of a protective role for total carotenoids, alpha-carotene and beta-carotene in cervical carcinogenesis and possibly for cryptoxanthin and lycopene as well.
This article has been cited by other articles:
![]() |
C. J. Kavanaugh, P. R. Trumbo, and K. C. Ellwood The U.S. Food and Drug Administration's Evidence-Based Review for Qualified Health Claims: Tomatoes, Lycopene, and Cancer J Natl Cancer Inst, July 18, 2007; 99(14): 1074 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishimukai and H. Hara Enteral Administration of Soybean Phosphatidylcholine Enhances the Lymphatic Absorption of Lycopene, but Reduces That of {alpha}-Tocopherol in Rats J. Nutr., August 1, 2004; 134(8): 1862 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mannisto, S. A. Smith-Warner, D. Spiegelman, D. Albanes, K. Anderson, P. A. van den Brandt, J. R. Cerhan, G. Colditz, D. Feskanich, J. L. Freudenheim, et al. Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle and A. R. Giuliano Chapter 4: Genital Tract Infections, Cervical Inflammation, and Antioxidant Nutrients--Assessing Their Roles as Human Papillomavirus Cofactors J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sedjo, D. J. Roe, M. Abrahamsen, R. B. Harris, N. Craft, S. Baldwin, and A. R. Giuliano Vitamin A, Carotenoids, and Risk of Persistent Oncogenic Human Papillomavirus Infection Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 876 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Schiff, R. E. Patterson, R. N. Baumgartner, M. Masuk, L. van Asselt-King, C. M. Wheeler, and T. M. Becker Serum Carotenoids and Risk of Cervical Intraepithelial Neoplasia in Southwestern American Indian Women Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1219 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Keefe, M. J. Schell, C. Brewer, M. McHale, W. Brewster, J. A. Chapman, G. S. Rose, D. S. McMeeken, W. Lagerberg, Y.-M. Peng, et al. A Randomized, Double Blind, Phase III Trial Using Oral {beta}-Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alberg, J. Selhub, K. V. Shah, R. P. Viscidi, G. W. Comstock, and K. J. Helzlsouer The Risk of Cervical Cancer in Relation to Serum Concentrations of Folate, Vitamin B12, and Homocysteine Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 761 - 764. [Abstract] [Full Text] |
||||
![]() |
E. Giovannucci Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature J Natl Cancer Inst, February 17, 1999; 91(4): 317 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |